Researchers analyzed 60 patients undergoing surgery and anesthesia with two widely used intravenous anesthetic drugs — propofol and remifentanil. Patients were randomly assigned to also receive the sedative dexmedetomidine or an inactive placebo.
The study found that the amounts of anesthetic drugs needed to induce anesthesia were significantly lower in patients receiving dexmedetomidine. The propofol induction dose was 30 percent lower and the remifentanil induction dose 25 percent lower, compared to the doses in patients receiving placebo. The study also found evidence of an analgesic effect of dexmedetomidine.
More Articles on Anesthesia:
Crystal Clear Solutions Develops Anesthesia Guide App for Surgical Procedures
AllCare Clinical Associates Appoints Dr. Frank Sutton as Partner
University of Michigan Health Startup Receives FDA Clearance for Patient Monitoring Software
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
